{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:19:00Z","timestamp":1793830740167,"version":"4.6.1"},"reference-count":25,"publisher":"Baishideng Publishing Group Inc.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Hepatol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>A new nomenclature of metabolic associated steatotic liver disease (MASLD) was proposed in 2023, thus expanding the diagnostic name of \u201cMASLD combined with other etiologies\u201d.<\/jats:p>\n          <jats:p>AIM<\/jats:p>\n          <jats:p>To investigate the clinical profiles of patients with concurrent MASLD and chronic hepatitis B virus (HBV) infection.<\/jats:p>\n          <jats:p>METHODS<\/jats:p>\n          <jats:p>This study included participants from the Taiwan Bio-bank. The diagnostic criteria of MASLD encompassed hepatic steatosis and any cardio-metabolic risk factors. Positive hepatitis B surface antigen was considered indicative of chronic HBV infection. Dual etiology was defined as MASLD combined with chronic HBV infection (MASLD-HBV). Fibrosis 4 (FIB-4) score determined the severity of liver fibrosis, and atherosclerosis was diagnosed by the presence of carotid plaques on duplex ultrasound.<\/jats:p>\n          <jats:p>RESULTS<\/jats:p>\n          <jats:p>In a total of 18980 participants (mean age, 55.18 \u00b1 10.35 years; males, 30.42%), there were 7654 (40.3%) MASLD patients and 2128 (11.2%) HBV carriers. After propensity score matching for age and gender, HBV carriers had a lower percentage of MASLD than healthy controls. Those with dual etiology had higher aspartate aminotransferase, alanine aminotransferase (ALT), and FIB-4 levels, but lower gamma glutamyl transferase (GGT) levels than MASLD patients. In contrast, those with dual etiology had higher ALT and GGT levels, but lower FIB-4 than \u201cHBV alone\u201d patients. The risk of atherosclerosis was similar among these three groups.<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>MASLD-HBV patients have worse liver fibrosis severity than MASLD patients, but better liver fibrosis stage than \u201cHBV alone\u201d patients, suggesting a complex interaction between MASLD and chronic HBV infection.<\/jats:p>","DOI":"10.4254\/wjh.v16.i12.1429","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:26:26Z","timestamp":1732854386000},"page":"1429-1440","source":"Crossref","is-referenced-by-count":11,"title":["Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection"],"prefix":"10.4254","volume":"16","author":[{"given":"Shao-Wen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Han","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7570\/jomes23052"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60207-5"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2015.06.003"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101526"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-3052"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13010068"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2024.01.014"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14430"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2020.03.10"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/gix110"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10449-x"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2023.07.010"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06300.x"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072049"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.09.013"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15575"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100836"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i20.3056"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06801.x"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-019-01594-6"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-018-9877-7"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.040"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13113"}],"container-title":["World Journal of Hepatology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v16\/i12\/1429.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v16\/i12\/1429.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:27:06Z","timestamp":1732854426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v16\/i12\/1429.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":25,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.4254\/wjh.v16.i12.1429","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}